This inventor holds 10 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Esteve Pharmaceuticals, S.a., Laboratorios Del Dr. Esteve S.a.. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
9 out of 34 
1 out of 150 Years Active: 2018-2023
Title: **Marina Virgili-Bernado: A Trailblazer in Pharmaceutical Innovations**
Introduction
Marina Virgili-Bernado, a renowned inventor based in Barcelona, Spain, has made significant contributions to the field of pharmaceuticals, particularly in developing innovative compounds for drug treatment. With a remarkable portfolio of 10 patents, her work demonstrates a commitment to advancing healthcare and addressing critical medical challenges.
Latest Patents
Among her latest inventions are two notable patents. The first, titled **Oxadiazaspiro Compounds for the Treatment of Drug Abuse and Addiction**, relates to compounds exhibiting pharmacological activity towards the sigma (σ) receptor. These oxadiazaspiro compounds hold promise for therapeutic applications against drug abuse and addiction, covering processes of preparation, pharmaceutical compositions, and therapeutic use.
The second patent, **Quinoline and Isoquinoline Derivatives for Treating Pain and Pain-Related Conditions**, introduces innovative compounds that show significant affinity and activity towards the α2δ subunit of voltage-gated calcium channels (VGCC). These compounds demonstrate dual activity against both VGCC and the noradrenaline transporter (NET), providing new avenues for pain management.
Career Highlights
Marina has worked with prestigious pharmaceutical companies like Esteve Pharmaceuticals and Laboratorios del Dr. Esteve, where she has leveraged her expertise to bring her innovative ideas to fruition. Her dedication to research and development has positioned her as a leader in her field.
Collaborations
Throughout her career, Marina has collaborated with esteemed colleagues such as Carmen Almansa-Rosales and Carlos Alegret-Molina. These partnerships have fostered an environment of innovation and knowledge sharing, contributing to the advancement of their collective pharmaceutical projects.
Conclusion
Marina Virgili-Bernado stands out as a pivotal figure in the realm of pharmaceutical invention, contributing valuable patents that aim to address pressing health issues like drug addiction and pain management. Her innovative spirit and collaborative approach continue to inspire others in the field, ensuring that her legacy will influence future developments in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile